anti-Ebola mAbs (Medicago)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-Ebola mAbs (Medicago)
Drug Alias Nameanti-Ebola antibodies (Medicago)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedicago Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedicago Inc
Active IndicationsN/A
Inactive IndicationsHemorrhagic Fever, Ebola

Other Information

ATC CodeN/A
Related LinksN/A